$15.49
+
$0.14 (0.91%)
End-of-day quote: 05/10/2024
ASX:TLX
Telix Pharmaceuticals Profile
Data Unavailable
Country
Industry:
Biological Products, Except Diagnostic Substances
Founded:
2015
IPO Date:
11/15/2017
ISIN Number:
I_AU000000TLX2
Contact Details
Address:
55 Flemington Road, Suite 401, North Melbourne, Victoria, 3051, Australia
Phone Number
61 3 3093 3897
Key Executives
CEO:
Behrenbruch, Christian
CFO
Smith, Darren
COO:
Patti, Darren
